91 related articles for article (PubMed ID: 26206318)
1. Preoperative diagnosis with versus without MRI in resection for hepatocellular carcinoma.
Aramaki O; Takayama T; Higaki T; Nakayama H; Okubo T; Midorikawa Y; Moriguchi M
Surgery; 2015 Dec; 158(6):1512-20. PubMed ID: 26206318
[TBL] [Abstract][Full Text] [Related]
2. Prognostic performance of preoperative gadoxetic acid-enhanced MRI in resectable hepatocellular carcinoma.
Shim JH; Han S; Shin YM; Lee YJ; Lee SG; Kim KM; Lim YS; Lee HC
J Magn Reson Imaging; 2015 Apr; 41(4):1115-23. PubMed ID: 24841479
[TBL] [Abstract][Full Text] [Related]
3. Anatomical versus non-anatomical resection for hepatocellular carcinoma.
Marubashi S; Gotoh K; Akita H; Takahashi H; Ito Y; Yano M; Ishikawa O; Sakon M
Br J Surg; 2015 Jun; 102(7):776-84. PubMed ID: 25847111
[TBL] [Abstract][Full Text] [Related]
4. Marginal survival benefit in the treatment of early hepatocellular carcinoma.
Midorikawa Y; Takayama T; Shimada K; Nakayama H; Higaki T; Moriguchi M; Nara S; Tsuji S; Tanaka M
J Hepatol; 2013 Feb; 58(2):306-11. PubMed ID: 23063418
[TBL] [Abstract][Full Text] [Related]
5. Gadoxetic acid-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma.
Kim SH; Kim SH; Lee J; Kim MJ; Jeon YH; Park Y; Choi D; Lee WJ; Lim HK
AJR Am J Roentgenol; 2009 Jun; 192(6):1675-81. PubMed ID: 19457834
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of prognostic factors on recurrence after curative resections for hepatocellular carcinoma.
Han JH; Kim DG; Na GH; Kim EY; Lee SH; Hong TH; You YK
World J Gastroenterol; 2014 Dec; 20(45):17132-40. PubMed ID: 25493027
[TBL] [Abstract][Full Text] [Related]
7. Impact of preoperative fine-needle aspiration cytologic examination on clinical outcome in patients with hepatocellular carcinoma in a tertiary referral center.
Ng KK; Poon RT; Lo CM; Liu CL; Lam CM; Ng IO; Fan ST
Arch Surg; 2004 Feb; 139(2):193-200. PubMed ID: 14769580
[TBL] [Abstract][Full Text] [Related]
8. A survival benefit of major hepatectomy for hepatocellular carcinoma identified by preoperative [18F] fluorodeoxyglucose positron emission tomography in patients with well-preserved hepatic function.
Ahn SG; Jeon TJ; Lee SD; Kim SH; Cho HJ; Yun M; Park YN; Lee JD; Park SJ; Kim KS
Eur J Surg Oncol; 2013 Sep; 39(9):964-73. PubMed ID: 23859893
[TBL] [Abstract][Full Text] [Related]
9. Implications of discordant findings between hepatic angiography and cross-sectional imaging in transplant candidates with hepatocellular carcinoma.
Young K; Fidelman N; Yao FY; Hills NK; Kohi MP; Kolli KP; Taylor AG; Kerlan RK
Liver Transpl; 2015 Apr; 21(4):454-67. PubMed ID: 25678220
[TBL] [Abstract][Full Text] [Related]
10. Preoperative predictors of microvascular invasion in multinodular hepatocellular carcinoma.
Zhao WC; Fan LF; Yang N; Zhang HB; Chen BD; Yang GS
Eur J Surg Oncol; 2013 Aug; 39(8):858-64. PubMed ID: 23669199
[TBL] [Abstract][Full Text] [Related]
11. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.
Zytoon AA; Ishii H; Murakami K; El-Kholy MR; Furuse J; El-Dorry A; El-Malah A
Jpn J Clin Oncol; 2007 Sep; 37(9):658-72. PubMed ID: 17766723
[TBL] [Abstract][Full Text] [Related]
12. Is liver resection for hepatocellular carcinoma in cirrhotic patients with high preoperative serum alanine aminotransferase level unadvisable?
Lai CY; Wu CC; Wang J; Yu CC; Cheng SB; Yeh DC; Peng FK
Hepatogastroenterology; 2014 Oct; 61(135):2068-76. PubMed ID: 25713912
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of early hepatocellular carcinoma.
Inoue K; Takayama T; Higaki T; Watanabe Y; Makuuchi M
Liver Transpl; 2004 Feb; 10(2 Suppl 1):S16-9. PubMed ID: 14762833
[TBL] [Abstract][Full Text] [Related]
14. Is serum alpha-fetoprotein useful for predicting recurrence and mortality specific to hepatocellular carcinoma after hepatectomy? A test based on propensity scores and competing risks analysis.
Shim JH; Yoon DL; Han S; Lee YJ; Lee SG; Kim KM; Lim YS; Lee HC; Chung YH; Lee YS
Ann Surg Oncol; 2012 Nov; 19(12):3687-96. PubMed ID: 22644512
[TBL] [Abstract][Full Text] [Related]
15. Treatment of stage IVA hepatocellular carcinoma: should we reappraise the role of surgery?
Chirica M; Scatton O; Massault PP; Aloia T; Randone B; Dousset B; Legmann P; Soubrane O
Arch Surg; 2008 Jun; 143(6):538-43; discussion 543. PubMed ID: 18559745
[TBL] [Abstract][Full Text] [Related]
16. Assessment of preoperative magnetic resonance imaging staging in patients with hepatocellular carcinoma undergoing resection compared with the seventh American Joint Committee on Cancer System.
An C; Choi GH; Lee HS; Kim MJ
Invest Radiol; 2012 Nov; 47(11):634-41. PubMed ID: 22814590
[TBL] [Abstract][Full Text] [Related]
17. Long-term survival after recurrent hepatocellular carcinoma in liver transplant patients: clinical patterns and outcome variables.
Kornberg A; Küpper B; Tannapfel A; Katenkamp K; Thrum K; Habrecht O; Wilberg J
Eur J Surg Oncol; 2010 Mar; 36(3):275-80. PubMed ID: 19857941
[TBL] [Abstract][Full Text] [Related]
18. The effect of age on the long-term prognosis of patients with hepatocellular carcinoma after resection surgery: a propensity score matching analysis.
Su CW; Lei HJ; Chau GY; Hung HH; Wu JC; Hsia CY; Lui WY; Su YH; Wu CW; Lee SD
Arch Surg; 2012 Feb; 147(2):137-44. PubMed ID: 22006855
[TBL] [Abstract][Full Text] [Related]
19. Laparoscopic liver resection for hepatocellular carcinoma in cirrhosis: long-term outcomes.
Belli G; Fantini C; Belli A; Limongelli P
Dig Surg; 2011; 28(2):134-40. PubMed ID: 21540599
[TBL] [Abstract][Full Text] [Related]
20. The effect of preoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma.
Zhang Z; Liu Q; He J; Yang J; Yang G; Wu M
Cancer; 2000 Dec; 89(12):2606-12. PubMed ID: 11135222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
